[go: up one dir, main page]

WO1997049812A3 - Procede d'extraction et d'epuration de proteine osp recombinee sans fraction lipidique - Google Patents

Procede d'extraction et d'epuration de proteine osp recombinee sans fraction lipidique Download PDF

Info

Publication number
WO1997049812A3
WO1997049812A3 PCT/AT1997/000136 AT9700136W WO9749812A3 WO 1997049812 A3 WO1997049812 A3 WO 1997049812A3 AT 9700136 W AT9700136 W AT 9700136W WO 9749812 A3 WO9749812 A3 WO 9749812A3
Authority
WO
WIPO (PCT)
Prior art keywords
lipidised
osp
extracting
protein
purifying recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/AT1997/000136
Other languages
German (de)
English (en)
Other versions
WO1997049812A2 (fr
Inventor
Artur Mitterer
Christa Tauer
Ian Livey
Friedrich Dorner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Priority to JP10501944A priority Critical patent/JP2000516444A/ja
Priority to EP97926912A priority patent/EP0973909A2/fr
Publication of WO1997049812A2 publication Critical patent/WO1997049812A2/fr
Priority to NO985902A priority patent/NO985902L/no
Anticipated expiration legal-status Critical
Publication of WO1997049812A3 publication Critical patent/WO1997049812A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne une protéine OspC sans fraction lipidique, un procédé de préparation de protéines Osp et des vaccins qui contiennent ces protéines recombinées.
PCT/AT1997/000136 1996-06-21 1997-06-19 Procede d'extraction et d'epuration de proteine osp recombinee sans fraction lipidique Ceased WO1997049812A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP10501944A JP2000516444A (ja) 1996-06-21 1997-06-19 組換え非脂質化Ｏｓｐタンパクを回収及び精製する方法
EP97926912A EP0973909A2 (fr) 1996-06-21 1997-06-19 Procede d'extraction et d'epuration de proteine osp recombinee sans fraction lipidique
NO985902A NO985902L (no) 1996-06-21 1998-12-16 FremgangsmÕte ved ekstrahering og rensning av rekombinant, ikke-lipidert Osp-protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0110696A AT405940B (de) 1996-06-21 1996-06-21 Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein
ATA1106/96 1996-06-21

Publications (2)

Publication Number Publication Date
WO1997049812A2 WO1997049812A2 (fr) 1997-12-31
WO1997049812A3 true WO1997049812A3 (fr) 1999-11-04

Family

ID=3506722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT1997/000136 Ceased WO1997049812A2 (fr) 1996-06-21 1997-06-19 Procede d'extraction et d'epuration de proteine osp recombinee sans fraction lipidique

Country Status (7)

Country Link
EP (1) EP0973909A2 (fr)
JP (1) JP2000516444A (fr)
AT (1) AT405940B (fr)
CA (1) CA2259636A1 (fr)
CZ (1) CZ425398A3 (fr)
NO (1) NO985902L (fr)
WO (1) WO1997049812A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1645283A1 (fr) * 2004-10-08 2006-04-12 Chiron Behring GmbH & Co. KG Composition de vaccin combiné
ES2421885T3 (es) * 2008-12-12 2013-09-06 Euroimmun Medizinische Labordiagnostika Ag Polipéptidos y procedimiento para la detección específica de anticuerpos en pacientes con una infección por Borrelia
CN114295745B (zh) * 2021-12-23 2023-09-08 辽宁成大生物股份有限公司 一种水痘减毒活疫苗中二甲基亚砜残留量的检测方法
CN115267027B (zh) * 2022-08-29 2023-05-02 上海市精神卫生中心（上海市心理咨询培训中心） 一种用于检测精神类药物的试剂盒和检测方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025596A2 (fr) * 1993-04-29 1994-11-10 Immuno Aktiengesellschaft FORMULATION IMMUNOGENE DE VACCINS A BASE D'ANTIGENES OspC, DESTINEE A LA PREVENTION ET AU TRAITEMENT DE LA MALADIE DE LYME ET PROCEDES DE RECOMBINAISON POUR LA PREPARATION DE CES ANTIGENES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620862A (en) * 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025596A2 (fr) * 1993-04-29 1994-11-10 Immuno Aktiengesellschaft FORMULATION IMMUNOGENE DE VACCINS A BASE D'ANTIGENES OspC, DESTINEE A LA PREVENTION ET AU TRAITEMENT DE LA MALADIE DE LYME ET PROCEDES DE RECOMBINAISON POUR LA PREPARATION DE CES ANTIGENES

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GONDOLF KB ET AL: "Isolation of an outermembrane protein complex from Borrelia burgdorgeri by n-butanol extraction and high-performance ion-exchange chromatography", JOURNAL OF CHROMATOGRAPHY., vol. 521, 1990, AMSTERDAM NL, pages 325 - 334, XP002041529 *
MA Y ET AL: "Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties", INFECTION AND IMMUNITY., vol. 61, no. 3, 1993, WASHINGTON US, pages 3843 - 3853, XP002041528 *
PADULA S.J. ET AL: "Molecular characterization and expression of p23 (OspC) from a north american strain of Borrelia burgdorferi", INFECTION AND IMMUNITY., vol. 61, 1993, WASHINGTON US, pages 5097 - 5105, XP002049935 *
PROBERT W.S. ET AL: "Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen", INFECTION AND IMMUNITY., vol. 62, no. 5, 1994, WASHINGTON US, pages 1920 - 1926, XP002049934 *

Also Published As

Publication number Publication date
CZ425398A3 (cs) 1999-03-17
JP2000516444A (ja) 2000-12-12
NO985902D0 (no) 1998-12-16
NO985902L (no) 1999-02-19
WO1997049812A2 (fr) 1997-12-31
CA2259636A1 (fr) 1997-12-31
ATA110696A (de) 1999-05-15
EP0973909A2 (fr) 2000-01-26
AT405940B (de) 1999-12-27

Similar Documents

Publication Publication Date Title
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
AU1009797A (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones
AU5252396A (en) Method for preparing a modified solid oxide
AU2153997A (en) Process for preparing 1,3-propanediol
AU5436898A (en) A method for generating a directed, recombinant fusion nucleic acid
AU5678396A (en) Methods of preparing soluble, oligomeric proteins
AU4782197A (en) Method for regenerating titanium silicalite catalysts
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
AU5317398A (en) Method for preparing cyclopropylamines
AU3866197A (en) Novel DNA and process for preparing protein using the DNA
ZA97942B (en) E1 compression control method.
AU4511197A (en) Purified proteins, recombinant DNA sequences and processes for producing caffeine free beverages
EP0613634A3 (fr) Procédé de fabrication de bâtons, en particulier de bâtons cosmétiques.
WO1997049812A3 (fr) Procede d'extraction et d'epuration de proteine osp recombinee sans fraction lipidique
AU3255997A (en) Process for preparing 1,3-alkanediols
AU9034298A (en) A simple, environmentally benign, method for purifying protein
WO1997029194A3 (fr) Preparation d'acide l-ascorbique
CA2194032A1 (fr) Sequence d'adn fusionnee, proteine fusionnee exprimee par ladite sequence d'adn et methode d'expression de ladite proteine fusionnee
AU4115897A (en) Process for preparing 6-aminocapronitrile
AU7847298A (en) Novel substituted 3H -benzoxazole-2-thiones and 3H -benzothiazole-2thi ones derivatives, method for preparing them and pharmaceutical comp ositions containing them
ZA988570B (en) Nucleic acids, recombinant cells and a process for preparing immunogenic compositions.
ZA975198B (en) Improved process for preparing potassium clavulanate.
AU4386796A (en) Process for preparing aliphatic alpha,omega-aminonitriles
IL131294A0 (en) Method for preparing 3,3-dimethylbutyraldehyde
AU7673498A (en) Process for preparing cyclic oligosiloxanes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA CZ HU JP NO US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2259636

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2259636

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PV1998-4253

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 1997926912

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1998-4253

Country of ref document: CZ

AK Designated states

Kind code of ref document: A3

Designated state(s): CA CZ HU JP NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

NENP Non-entry into the national phase

Ref country code: CA

WWP Wipo information: published in national office

Ref document number: 1997926912

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997926912

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1998-4253

Country of ref document: CZ